Updated: May 19, 2026

James R. Empfield

XENEXenon Pharmaceuticals Inc.SEC CIK: 0001665430
Estimated Net Worth
$2.6 Million
Last Updated: May 19, 2026 02:22 AM EST

Transaction Summary

Total Transactions4
Buy-Sell Ratio0.00
Buy Transactions0
Sell Transactions1

Transaction Volume

Total Volume-$2.21M
Net Volume$2.21M
Buy Volume$0
Sell Volume-$2.21M

Trade Analysis

AVG Trade Size-$553.03K
Largest Trade$0
Most Active MonthMar
Most Active Year2024

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

James R. Empfield has an estimated net worth of $2.6 Million. This is based on reported shares in Xenon Pharmaceuticals Inc..



2022 was James R. Empfield's most active year for acquiring shares with 2 total transactions. James R. Empfield's most active month to acquire stocks was the month of February. 2022 was James R. Empfield's most active year for disposing of shares, totalling 5 transactions. James R. Empfield's most active month to dispose stocks was the month of July. 2022 saw James R. Empfield paying a total of $275,750.00 for 65,000 shares, this is the most they've acquired in one year. In 2022 James R. Empfield cashed out on 130,000 shares for a total of $2,487,889.58, their largest year based on trade value.

Holdings & Transactions

XENExenon pharmaceuticals inc.
EVP, Drug Discovery
Updated: Mar 12, 2024VIEW QUOTE
Form TypeSEC Filing
65.00K65.00KMar 11View
75.00K75.00KMar 10View
-0.8765.00K$21.26-$2.21M10.00KAug 12View
View